Concepts and challenges of biosimilars to mitigate the oncology drug expenses
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
1. autor: | Tania, Umme |
---|---|
Kolejni autorzy: | Haque , Md. Aminul |
Format: | Praca dyplomowa |
Język: | en_US |
Wydane: |
Brac University
2021
|
Hasła przedmiotowe: | |
Dostęp online: | http://hdl.handle.net/10361/15111 |
Podobne zapisy
-
Biosimilar in lymphoma treatment
od: Tanisha, Mehrin Haque
Wydane: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
od: Tabassum, Turana
Wydane: (2022) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
od: Tania, Umme
Wydane: (2023) -
Advancement of Antibody-Drug conjugates in cancer treatment: A review
od: Sagar, Baejid Hossain
Wydane: (2022) -
Immunotherapeutic approaches to treat cancer: Prospects and challenges
od: Fred, Namanda Rogers
Wydane: (2021)